Physician profile
Jill A Ward
NPI 1538441316
$278,511.22
in general payments reported to CMS, 2019-2025
7 companies · $82K in 2025
The $82K reported for 2025 was more than what 99% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2021: $4,681 · 2022: $44K · 2023: $95K · 2024: $52K · 2025: $82K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $159K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $60K · Food and Beverage: $5,709 · Travel and Lodging: $4,026.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $159,461.51 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $60,050.00 |
| Food and Beverage | $5,708.63 |
| Travel and Lodging | $4,026.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Plasma INC. | $122,782.30 | 2023-2025 | |
| Inari Medical, INC. | $99,439.08 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Arkray USA, INC. | $32,679.21 | 2025 | |
| Csl Behring | $18,271.49 | 2022-2023 | Kcentra |
| Stryker Corporation | $4,788.98 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Flowtriever |
| Abiomed | $446.08 | 2019-2025 | |
| Boston Scientific Corporation | $104.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Ward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.